The CMS-FDA RAPID Coverage Pathway Is a Capital Markets Event Disguised as a Coverage Policy: What the Regulatory-Reimbursement Clock Synch Means for Medtech Investment & Device Commercialization

Thoughts on Healthcare Markets & Technology Podcast

0:00

-4:49

Paid episode

The full episode is only available to paid subscribers of Thoughts on Healthcare Markets & Technology

The CMS-FDA RAPID Coverage Pathway Is a Capital Markets Event Disguised as a Coverage Policy: What the Regulatory-Reimbursement Clock Synch Means for Medtech Investment & Device Commercialization

CMS and FDA just synchronized regulatory approval and Medicare coverage timelines for medical devices, and the capital markets have not priced it yet.

May 04, 2026

∙ Paid

The RAPID pathway, announced jointly by CMS and FDA on April 23, 2026, attempts to synchronize the regulatory approval timeline with the Medicare coverage determination timeline for the first time in US device commercialization history. This episode breaks down exactly what that means for medtech investors and device company operators.

We examine the spe…

Continue reading this post for free, courtesy of Thoughts on Healthcare.

Or purchase a paid subscription.